Search for: "RISING PHARMACEUTICALS, INC."
Results 401 - 420
of 466
Sort by Relevance
|
Sort by Date
18 Jun 2009, 1:20 am
Companies seek to sanction DOJ over lost evidence in drug pricing case
"Health care products company Abbott Laboratories and pharmaceutical company Dey Inc. asked a Massachusetts federal court to sanction the U.S. [read post]
18 May 2009, 5:24 am
: Omnicare, Inc v OHIM, Astellas Pharma GmbH (Class 46) CFI delivers judgment in case concerning ability of designer who assigns business and related IP to another company, to object when the company tries to register his name as a CTM: Elio Fiorucci v OHIM (IPKat) CFI: Good faith irrelevant when selling non-misleading sausages: Alberto Severi, in his own name and representing Cavazzuti e figli SpA, now known as Grandi Salumifici Italiani SpA v Regione Emilia-Romagna (IPKat) CFI clarifies… [read post]
26 Apr 2009, 6:16 pm
By analogy this could include the pharmaceutical industry as well. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) Superior Court of Justice reviews date from which TRIPS came into effect - Patent term cutbacks in Brazil and pharmaceutical pipelines (IP Think Tank) (IP Think Tank) (IP tango) Harmonisation in Denmark: Patents covering pharmaceutical compositions may now be designated as basic patents (The SPC Blog) General GSK reports on corporate responsibility activities 2008/9 including commitment… [read post]
27 Mar 2009, 7:20 am
(Technology Transfer Tactics) Global - Trade Marks / Brands Starfish and spiders – trade mark hazards for decentralised, non-hierarchical organisations (Property, intangible) Global - Patents Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Agreement to simplify international patent classification system (WIPO) (IPKat) (Competitive Info) Concerns voiced at WIPO over potential… [read post]
27 Mar 2009, 5:15 am
(In the Arkansas Prempro MDL, which consists of thousands of cases, the judge has ordered the plaintiffs to complete discovery involving defendants Pfizer Inc. and Wyeth Pharmaceuticals Inc. by Sept. 1 , 2009) . [read post]
13 Mar 2009, 4:00 am
(Securing Innovation) PriorSmart.com search tool, tracking patent documents (Competitive Info) (Patently-O) Patent damages as an incentive to transact (IP finance) IPscore, new patent evaluation toy (IP finance) Patent portfolios can pull companies out of financial rut (Law360) Global - Copyright Expanding the public domain: part zero (Creative Commons) Australia Pioneering decision on non-use: Pioneer Computers Australia Pty Limited v Pioneer KK (Australian Trade… [read post]
14 Feb 2009, 11:56 am
Class Action Practice Is on the Rise Across Many Sectors Class actions in federal court have risen steadily in recent years, increasing 72% between 2001 and 2007 and averaging 4,000-5,000 per year as of mid-2007. [read post]
11 Feb 2009, 1:55 pm
The agency sent letters to 16 manufacturers of 24 products including Purdue Pharma LP, the maker of OxyContin, which is available in an extended-release form; a unit of Johnson & Johnson that makes a fentanyl patch; and King Pharmaceuticals Inc., the maker of an extended-release form of morphine. [read post]
3 Feb 2009, 4:23 am
Pfizer, Inc., Docket Nos. 05-4863-cv (L), 05-6768-cv (CON), slip op. (2d Cir. [read post]
3 Feb 2009, 1:40 am
JPMorgan Chase & Co., Bank of America Corp., Barclays Plc, Citigroup Inc. and Goldman Sachs Group Inc. assembled the loan package for Pfizer. [read post]
25 Jan 2009, 2:36 pm
Morgan Stanley and Evercore Partners Inc. are counseling Wyeth, the people said. [read post]
13 Jan 2009, 4:05 am
Inspire Pharmaceuticals Inc., 549 F.3d 618 (4th Cir. 2008) [Slip Opn., at 2]. [read post]
8 Jan 2009, 12:32 pm
First DataBank, Inc., 244 F.R.D. 79 (D. [read post]
23 Dec 2008, 7:00 pm
It was withdrawn at Par Pharmaceuticals based on the Board of Directors' commitment to adopt the policy in 2009. [read post]
13 Nov 2008, 1:52 pm
Yuba Power Products, Inc., explained the rationale for what it called "strict liability":We need not recanvass the reasons for imposing strict liability on the manufacturer. [read post]
21 Oct 2008, 8:15 pm
Merrell Dow Pharmaceuticals seems to break down as well. [read post]
20 Oct 2008, 10:23 am
Investors have to prove that their losses were because of managerial fraud and not a result of the ordinary fluctuations in the market.[23] Recently two major Supreme Court decisions have made it even more difficult for investors to bring fraud claims against corporate executives.[24] The first obstacle comes from a 2005 ruling.[25] The Supreme Court held that alleging a director's general misrepresentation caused inflated share prices and therefore loss to… [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
